Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Abhasnee Sobhonslidsuk"'
Autor:
Vichapat Tharanon, Pansa Iamrahong, Jutamas Tuamsem, Kunvadee Choochaeam, Titinun Auamnoy, Abhasnee Sobhonslidsuk
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-6 (2024)
Abstract Background Tacrolimus is a potent calcineurin inhibitor (CNI) that is principally used as a first-line immunosuppressant for the prophylaxis of allograft rejection in liver transplantation (LT) patients. In clinical practice, prescribing the
Externí odkaz:
https://doaj.org/article/ba6b4ef9d84c4439a5ebb7e61ef592db
Autor:
Alan Chuncharunee, Songporn Oranratnachai, Lancharat Chuncharunee, Pongphob Intaraprasong, Ammarin Thakkinstian, Abhasnee Sobhonslidsuk
Publikováno v:
JGH Open, Vol 8, Iss 7, Pp n/a-n/a (2024)
Abstract Aim Liver transplantation (LT) is essential due to its curative efficacy, but liver‐graft shortages have limited its widespread application. Bridging locoregional therapy (LRT) before LT has been performed to prevent tumor progression, and
Externí odkaz:
https://doaj.org/article/d434032146de43b992404f15a68a5a8b
Autor:
Yogesh Krishnarao Gurav, Bhavani Shankara Bagepally, Natthakan Chitpim, Abhasnee Sobhonslidsuk, Mohan Digambar Gupte, Usa Chaikledkaew, Ammarin Thakkinstian, Montarat Thavorncharoensap
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0306293 (2024)
Several hepatitis A outbreaks have recently been reported in Kerala state, India. To inform coverage decision of hepatitis A vaccine in Kerala, this study aimed to examine the cost-effectiveness of 1) hepatitis A vaccination among children aged 1 yea
Externí odkaz:
https://doaj.org/article/7d4cbfa7b9bb47d3abe4bab7d029f3e9
Autor:
Supachaya Sriphoosanaphan, Witthawat Pantumongkol, Wantanee Kulpeng, Chanchai Charonpongsuntorn, Tawesak Tanwandee, Wattana Sukeepaisarnjaroen, Abhasnee Sobhonslidsuk, Pisit Tangkijvanich
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0300327 (2024)
BackgroundClinical trials have proven the efficacy and safety of atezolizumab combined with bevacizumab (A+B) in treating unresectable hepatocellular carcinoma (uHCC). This study aimed to assess the cost-utility of A+B compared to best supportive car
Externí odkaz:
https://doaj.org/article/5c1b485a9a3b4a7db281752a4fba8335
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Nonselective beta‐blockers (NSBBs) may exacerbate ascites by impairing cardiac function. This study evaluated the impact of achieving a heart rate target of 55–60 beats per minute (bpm) on ascites‐related death and complications from w
Externí odkaz:
https://doaj.org/article/b68dbbcfc3f5441f9239cd50a9b23ffb
Autor:
Thitiya Lukkunaprasit, Amarit Tansawet, Suparee Boonmanunt, Abhasnee Sobhonslidsuk, Gareth J. McKay, John Attia, Ammarin Thakkinstian
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common cause of chronic liver disease and can progress to nonalcoholic steatohepatitis and cirrhosis. This study aims to summarize the evidence for the effects of curcumin on
Externí odkaz:
https://doaj.org/article/c359f532a5ff443ab0f320fb826d5106
Autor:
Pattaraphorn Phornkittikorn, Surasak Kantachuvesiri, Abhasnee Sobhonslidsuk, Teerapat Yingchoncharoen, Sasisopin Kiertiburanakul, Jackrapong Bruminhent
Publikováno v:
Vaccines, Vol 12, Iss 5, p 541 (2024)
Background: Immunization against SARS-CoV-2 is essential for vulnerable solid organ transplant (SOT) recipients who are at risk of infection. However, there are concerns about suboptimal immunogenicity, especially in humoral immunity (HMI), and limit
Externí odkaz:
https://doaj.org/article/1c3aa44d053d4c9b8b3604d2f287c1be
Autor:
Tanawat Jongraksak, Alan Chuncharunee, Pongphob Intaraprasong, Amarit Tansawet, Ammarin Thakkinstian, Abhasnee Sobhonslidsuk
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundDirect-acting antivirals (DAA) are effective for chronic hepatitis C virus (HCV) treatment. However, their impact on overall survival (OS), hepatocellular carcinoma (HCC) occurrence, HCC-free survival, and liver function in patients with HC
Externí odkaz:
https://doaj.org/article/987b882e020b45d198ab49121865fd8a
Autor:
Sakkarin Chirapongsathorn, Tongluk Teerasarntipan, Krit Tipchaichatta, Tanita Suttichaimongkol, Naichaya Chamroonkul, Chalermrat Bunchorntavakul, Sith Siramolpiwat, Siwaporn Chainuvati, Abhasnee Sobhonslidsuk, Apinya Leerapun, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Tawesak Tanwandee, Sombat Treeprasertsuk
Publikováno v:
JGH Open, Vol 6, Iss 3, Pp 205-212 (2022)
Abstract Background and Aim Acute‐on‐chronic liver failure (ACLF) leads to multi‐organ failure related to high mortality rates. This study aimed to gather epidemiological data and validate a scoring system to predict mortality in ACLF. Methods
Externí odkaz:
https://doaj.org/article/621ae3e3fea84fcf9fceb302c1bdd558
Autor:
Phunchai Charatcharoenwitthaya, Virasak Wongpaitoon, Piyawat Komolmit, Wattana Sukeepaisarnjaroen, Pisit Tangkijvanich, Teerha Piratvisuth, Theeranun Sanpajit, Chinnavat Sutthivana, Chalermrat Bunchorntavakul, Abhasnee Sobhonslidsuk, Soonthorn Chonprasertsuk, Chotipong Siripipattanamongkol, Supatsri Sethasine, Tawesak Tanwandee, The THASL Collaborating Group for the Study of the Use of Direct-acting Antivirals for Chronic Hepatitis C
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background We investigated real-world effectiveness and safety of sofosbuvir and the nonstructural protein 5A inhibitors in the treatment of patients infected with hepatitis C virus (HCV) genotypes 1, 2, 3, 4, or 6. Methods We analyzed data
Externí odkaz:
https://doaj.org/article/483de3b67ce54340a6917026ca3188de